News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,253 Results
Type
Article (43819)
Company Profile (318)
Press Release (698103)
Multimedia
Podcasts (116)
Webinars (19)
Section
Business (210996)
Career Advice (2109)
Deals (36759)
Drug Delivery (124)
Drug Development (83421)
Employer Resources (176)
FDA (16829)
Job Trends (15503)
News (357377)
Policy (34130)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2614)
Accelerated approval (34)
Adcomms (26)
Allergies (149)
Alliances (51587)
ALS (174)
Alzheimer's disease (1698)
Antibody-drug conjugate (ADC) (327)
Approvals (17096)
Artificial intelligence (541)
Autoimmune disease (162)
Automation (41)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (21)
Biosimilars (198)
Biotechnology (188)
Bladder cancer (158)
Brain cancer (61)
Breast cancer (651)
Cancer (4914)
Cardiovascular disease (420)
Career advice (1788)
Career pathing (37)
CAR-T (287)
CDC (48)
Celiac Disease (2)
Cell therapy (762)
Cervical cancer (36)
Clinical research (71196)
Collaboration (1773)
Company closure (4)
Compensation (1181)
Complete response letters (65)
COVID-19 (2788)
CRISPR (99)
C-suite (888)
Cystic fibrosis (148)
Data (6313)
Decentralized trials (2)
Denatured (36)
Depression (137)
Diabetes (508)
Diagnostics (6789)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (262)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (235)
Earnings (91970)
Editorial (60)
Employer branding (21)
Employer resources (155)
Events (120326)
Executive appointments (1006)
FDA (20004)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1495)
Gene editing (206)
Generative AI (45)
Gene therapy (617)
GLP-1 (1015)
Government (4807)
Grass and pollen (7)
Guidances (385)
Healthcare (19063)
HIV (62)
Huntington's disease (46)
IgA nephropathy (85)
Immunology and inflammation (266)
Immuno-oncology (58)
Indications (117)
Infectious disease (3064)
Inflammatory bowel disease (198)
Inflation Reduction Act (14)
Influenza (119)
Intellectual property (259)
Interviews (327)
IPO (16922)
IRA (57)
Job creations (4070)
Job search strategy (1498)
JPM (64)
Kidney cancer (16)
Labor market (86)
Layoffs (576)
Leadership (34)
Legal (8425)
Liver cancer (92)
Longevity (15)
Lung cancer (662)
Lymphoma (382)
Machine learning (43)
Management (60)
Manufacturing (836)
MASH (170)
Medical device (13862)
Medtech (13917)
Mergers & acquisitions (20914)
Metabolic disorders (1309)
Multiple sclerosis (163)
NASH (17)
Neurodegenerative disease (327)
Neuropsychiatric disorders (91)
Neuroscience (2967)
Neurotech (1)
NextGen: Class of 2026 (6644)
Non-profit (4563)
Now hiring (68)
Obesity (620)
Opinion (288)
Ovarian cancer (168)
Pain (216)
Pancreatic cancer (231)
Parkinson's disease (284)
Partnered (34)
Patents (514)
Patient recruitment (500)
Peanut (59)
People (60937)
Pharmaceutical (90)
Pharmacy benefit managers (31)
Phase 1 (22098)
Phase 2 (31303)
Phase 3 (23455)
Pipeline (5454)
Policy (301)
Postmarket research (2655)
Preclinical (9389)
Press Release (68)
Prostate cancer (240)
Psychedelics (50)
Radiopharmaceuticals (291)
Rare diseases (878)
Real estate (6306)
Recruiting (72)
Regulatory (25434)
Reports (53)
Research institute (2440)
Resumes & cover letters (361)
Rett syndrome (27)
RNA editing (17)
RSV (80)
Schizophrenia (156)
Series A (246)
Series B (194)
Service/supplier (11)
Sickle cell disease (100)
Special edition (25)
Spinal muscular atrophy (160)
Sponsored (43)
Startups (3767)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (96)
The Weekly (78)
Vaccines (1042)
Venture capital (92)
Weight loss (405)
Women's health (92)
Worklife (18)
Date
Today (99)
Last 7 days (537)
Last 30 days (2322)
Last 365 days (30365)
2026 (3904)
2025 (30683)
2024 (35768)
2023 (40630)
2022 (51802)
2021 (56330)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33136)
2016 (32662)
2015 (38616)
2014 (32516)
2013 (27631)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (800)
Alabama (84)
Alaska (7)
Arizona (317)
Arkansas (14)
Asia (42168)
Australia (6752)
California (11433)
Canada (3335)
China (1143)
Colorado (482)
Connecticut (485)
Delaware (343)
Europe (90426)
Florida (1711)
Georgia (359)
Hawaii (3)
Idaho (61)
Illinois (886)
India (71)
Indiana (534)
Iowa (22)
Japan (446)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1401)
Massachusetts (8226)
Michigan (330)
Minnesota (635)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (78)
New Jersey (3039)
New Mexico (29)
New York (3021)
North Carolina (1490)
North Dakota (8)
Northern California (5581)
Ohio (337)
Oklahoma (22)
Oregon (46)
Pennsylvania (2317)
Puerto Rico (24)
Rhode Island (48)
South America (1175)
South Carolina (67)
South Dakota (1)
Southern California (4455)
Tennessee (177)
Texas (1765)
United States (40652)
Utah (340)
Vermont (1)
Virginia (280)
Washington D.C. (81)
Washington State (933)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
742,253 Results for "actinium pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand
Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies.
February 17, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies
February 11, 2026
·
2 min read
Press Releases
BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research
February 17, 2026
·
3 min read
Press Releases
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies
December 19, 2025
·
2 min read
Press Releases
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
December 17, 2025
·
4 min read
Press Releases
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
September 12, 2025
·
7 min read
Press Releases
SpectronRx Begins Commercial-Scale Production of High-Purity Actinium-225, Strengthening Global Supply for Cancer Therapies
Indiana-based radiopharmaceutical contract development and manufacturing organization producing Ac-225 at a scale
October 30, 2025
·
1 min read
Press Releases
SpectronRx’s Actinium-225 Master File Approved for Reference in Canadian Radiopharmaceutical Submissions
October 1, 2025
·
1 min read
Pharm Country
Actinium Pharmaceuticals Launches Actinium-225 Focused Strategic Initiative to Leverage Proprietary Cyclotron Based Manufacturing Technology to Address Growing Market Demand
Actinium Pharmaceuticals, Inc. announced that it has launched a strategic initiative focused on the manufacture of the highly sought after medical isotope Actinium-225 leveraging its propriety cyclotron-based method.
March 11, 2024
·
6 min read
Press Releases
Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics
June 23, 2025
·
4 min read
1 of 74,226
Next
